Comparison of Topical Tofacitinib and 0.1% Hypochlorous Acid in a Murine Atopic Dermatitis Model

BMC pharmacology & toxicology - United Kingdom
doi 10.1186/s40360-018-0232-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Process Utilities for Topical Treatment in Atopic Dermatitis

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2019English

The Use of Topical Calcineurin Inhibitors in Atopic Dermatitis

Open Dermatology Journal
Dermatology
2014English

Topical Steroid Therapy in Atopic Dermatitis in Theory and Practice

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2015English

679 Pharmacological Validation of a Mouse Model of Atopic Dermatitis Induced by Topical Calcipotriol

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Topical Hypochlorous Acid (HOCl) as a Potential Treatment of Pruritus

Current Dermatology Reports
Dermatology
2013English

Pss61 - Process Utilities for Topical Treatment in Atopic Dermatitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Topical Superantigen Exposure Induces Epidermal Accumulation of CD8+ T Cells, a Mixed Th1/Th2-Type Dermatitis and Vigorous Production of IgE Antibodies in the Murine Model of Atopic Dermatitis

Journal of Immunology
AllergyImmunology
2005English

Hyperoxygenation Attenuated a Murine Model of Atopic Dermatitis Through Raising Skin Level of ROS

PLoS ONE
Multidisciplinary
2014English

Addressing the Immunopathogenesis of Atopic Dermatitis: Advances in Topical and Systemic Treatment

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy